Tag: heartbeam
HeartBeam receives US FDA clearance for at-home arrhythmia assessment with cable-free...
HeartBeam has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s “groundbreaking” 12-lead electrocardiogram (ECG) synthesis software...
HeartBeam’s deep learning algorithms demonstrate high rates of accuracy in detecting...
HeartBeam has announced new study data demonstrating no significant differences in the detection of atrial fibrillation (AF), atrial flutter and sinus rhythm when the...
HeartBeam’s synthesised 12-lead ECG meets clinical endpoints in VALID-ECG study
HeartBeam has announced that its “groundbreaking” synthesised 12-lead electrocardiogram (ECG) successfully met the clinical endpoints in the VALID-ECG pivotal study. Thomas Deering (Piedmont Heart...
HeartBeam announces US FDA clearance for at-home, high-fidelity heart monitoring technology
HeartBeam has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance of the HeartBeam system for comprehensive arrhythmia assessment. A...
HeartBeam accquires LIVMOR assets
HeartBeam, a cardiac technology company that has developed the three-dimensional (3D)-vector electrocardiogram (VECG) platform for heart attack detection today announced the strategic acquisition of...
HeartBeam granted European patent for signal transformation from VECG to 12-lead...
HeartBeam, a cardiac technology company that has developed a 3D-vector electrocardiogram (ECG) platform for heart attack detection, has announced that a patent that enables...